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1. Introduction
  Many marine organisms produce a variety of chemicals for defense 
purposes; often serve as the basis for chemecological studies 
and also as a valuable source offering a vast choice of bioactive 
molecules for the development of novel pharmaceutical materials. 
This highly divergent genus, with >700 species worldwide, 
contribute differently to the chemical diversity of bioactive peptides 
with a peptide library of the order of 70 000 sequences generated 
from them[1]. These products exhibit exquisite selectivity of ion 
channels and receptor isoforms for being increasingly important in 
research and medicine[2,3]. A large proportion of natural compounds 
are extracted from marine invertebrates and many of them are under 
clinical trials[4]. 
  The physiological action and pharmacological potential of 
conopeptides in vertebrate and invertebrate nervous systems are 
presently being studied in many research laboratories of the world. 
Conotoxins represent extremely specific biological probes that offer 
researchers a tool to understand and discriminate between closely 
related receptors[5]. The simplicity of conotoxins has made them 
valuable natural source in the advancement of neuroscience research 
and consequent drug development[6]. Active research in the field of 
conotoxins involves to isolating, identify structural properties, and 
assessment of biological activity of individual peptides that possess 
the potential to be made into potent and selective therapeutic drugs. 
Scientists either use a small amount of purified native conotoxin 
or they use automated synthesis techniques to prepare milligram 
quantities of material for their investigations. Currently, only about 
0.2% of the conotoxin peptide library has been cataloged[7,8].
  This present work represents the geographical distribution of cone 
shells and diversity with special reference to Indian cone snails, 
The evolutionarily unique and ecologically diverse family Conidae presents fundamental 
opportunities for marine pharmacology research and drug discovery. The focus of this 
investigation is to summarize the worldwide distribution of Conus and their species 
diversity with special reference to the Indian coast. In addition, this study will contribute to 
understanding the structural properties of conotoxin and therapeutic application of Conus 
venom peptides. Cone snails can inject a mix of various conotoxins and these venoms are 
their major weapon for prey capture, and may also have other biological purposes, and 
some of these conotoxins fatal to humans. Conus venoms contain a remarkable diversity of 
pharmacologically active small peptides; their targets are an iron channel and receptors in 
the neuromuscular system. Interspecific divergence is pronounced in venom peptide genes, 
which is generally attributed to their species specific biotic interactions. There is a notable 
interspecific divergence observed in venom peptide genes, which can be justified as of biotic 
interactions that stipulate species peculiar habitat and ecology of cone snails. There are several 
conopeptides used in clinical trials and one peptide (Ziconotide) has received FDA approval for 
treatment of pain. This perspective provides a comprehensive overview of the distribution of 
cone shells and focus on the molecular approach in documenting their taxonomy and diversity 
with special reference to geographic distribution of Indian cone snails, structure and properties 
of conopeptide and their pharmacological targets and future directions.
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evolution of phylogeny, structural diversity of conopeptide chemistry 
and biochemistry, conopeptide sequences and their physiological 
applications of specific Conus peptides, pharmacological targets and 
future commissions.Additionally, this work presents an overview of 
conotoxins reported from Indian cone snails.
2. Distribution and ecology of cone shells
  Conus are the most diverse genus of marine invertebrates and 
contribute substantially to the great biodiversity in the tropical 
Indo–Pacific reef environments[9]. Speciation and rich endemism 
are evidenced by the morphology and toxicology of the genus 
Conus[1]. Conus is widely distributed throughout all tropical oceans 
comprising one-fourth the earth’s ocean area[10], yet roughly 60% 
of their habitation occur in the Indo-Pacific region. Over 20 species 
have been observed to co-occur on reef platforms, at the maximum 
of 27 species observed in Indonesia[11,12]. In more recent reports 
Kohn reported 36 species of Conus on the reef platform fringing 
Laing Island and 32 species on four small reefs of Near Madang 
of Northeast Papua Guinea[13]. The species Conus anemone and 
Conus victoriae is the dominant species in intertidal habitats in the 
inner region of the Dampier Archipelago. In favorable habitats their 
estimated densities were recorded 0.2–2.6 and 0.1–0.3 individuals/10 
m2, respectively. Both the species occurred predominantly under 
rocks, on sand or limestone substrate[14].
  The Indian coasts inter- and subtidal regions contain nearly 100 
species, but due to the lack of sufficient information, sixteen of 
the identified species found off the coast of India are still currently 
placed on the list of unverified species[15]. Conus generalis and 
Conus litoglyphus were considered as unverified species but have 
been confirmed as a species native to Indian Coastal waters[1,13,14]. 
According to the 1996 IUCN study, Conus africanus, Conus cepasi, 
Conus nobrei, and Conus zebroides are vulnerable and Conus kohni 
remains data deficient[16].
2.1. Biology of Conus
  The cone snail’s venom has secured its survival with its value 
in foraging and defensive strategies[5]. Cone snails are effective 
venomous predators of worms, other molluscs, and small fish 
by using a deadly combination of paralyzing neuronic peptide 
toxins. The singular preferential prey choice, discovered from the 
gut content and fecal analyses[11,17], of all the species, but a few 
have become a way to categorize the numerous species into three 
important groups that provide in general the projected threat level 
of their venom toward humans. The piscivorous class contains the 
smallest number of species, but is assessed as deadly to humans. A 
larger number of species belong to the molluscivorous class that is 
dangerous by means of their aggressive behavior (although some 
members have been implicated in unconfirmed fatalities). The 
largest vermivorous class contains about 80% of the genus and is 
found to be timorous and nonthreatening. Although diet diversity is 
a genus level examination, individual species tend to be specialized 
particularly where large numbers of congeners co-occur[15,17], and 
most Conus species hunt prey of only one of the three types listed 
above.
  However, the diets of a few species span more than one prey 
category. Conus californicus is the most notable exception with the 
broadest diet known of all Conus species; its diet includes fish, 
molluscs (including bivalves as well as gastropods), polychaetes 
and crustaceans[18]. Conus bullatus (C. bullatus) have been observed 
to feed on both fish and molluscs[19] as cited by Rockel et al[1]. 
Also, several vermivorous species, including Conus arenatus, Conus 
eburneus (C. eburneus), Conus miliaris, Conus lividus and Conus 
sponsalis, have been reported to prey on sedentary polychaetes, errant 
polychaetes and hemichordates in different geographic locations; 
C. eburneus and Conus tessulatus occasionally prey on fishes as 
well[11,20]. Geometric morphometric techniques allow for the direct 
quantification and analysis of variation in biological shapeand have 
been used in studies in systematic biology. Geometric morphometric 
analysis of shell shape variations in Conus sp, the results of this 
study established the utility of geometric morphometric methods 
in capturing the interspecific differences in shell form in the genus 
Conus sp[21]. 
  Human envenomation [principally by piscivorous Conus geographus 
(C. geographus)] has caused around 30 recorded fatalities. The first 
recorded death by envenomation in 1705 has lately been attributed 
to molluscivore Conus textile[22], and since cone shell popularity 
ornamentally has grown internationally, subsequent envenomations 
(including casualties) has likely gone unreported. Therefore, it must 
be emphasized that collecting live cone snails from the field is a 
perilous undertaking and requires assiduousness, experience with 
species identification and ethology[23].
2.2. Molecular taxonomy and phylogeny of Conus species
  Most taxonomists place all of the venomous neogastropod taxa 
in the single superfamily, Conoidea[24,25]. Though the efforts to 
subdivide the genus conus has found little support, the recently 
proposed alternative classification based on shell and radula[26], 
recognizing 4 families and 80 genera has found some acceptance. 
The difficulty in Conus taxonomy involves multiple examples 
of species complexes[27,28]. Distinctive species taxonomical 
confirmation has been challenging, descriptions and identification 
has entirely depend on shell characters, primarily color patterns, and 
these habituallylook to integrate among putative species.
  Pigmentation pattern of cone shells is complex phenotypes, itvary 
significantlymore with closely related species, but the complexity of 
the color patterns makes it difficult to characterize their similarities 
and differences. Gong et al[29] studied an attempt to resolve this 
problem by combining phylogenetic methods with a realistic 
developmental model that can generate pigmentation patterns in the 
diverse cone shells. He found phylogenetic signals are of the primary 
neural network and in the presence or absence of hidden network, 
suggests that the model reasonably approximates the developmental 
processes underlying pigmentation patterns in the Conus species. In 
contrast, various features of the pigmentation patterns, such as the 
presence of dots and stripes, do not have a significant phylogenetic 
signal.
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  DNA barcoding has been proposed as a technique that will make 
confirmation of species identification faster and more accessible 
using a small fragment of DNA sequence, peculiarly in species 
with complex morphologycharacteristic[30]. Species identification 
using DNA Barcoding should be kept clear and distinct from 
other proposed uses of DNA sequence information in taxonomy 
and biodiversity studies, such as ‘‘DNA taxonomy’’ using DNA 
sequences[31,32]. This recent usage, and its subsequent successes, 
have induced criticism and taxonomic debate.
  One method is grounded on the degree of sequence variation 
between species, and the alternative technique involves the recovery 
of species as discrete clades (monophyly) on a phylogenetic tree.
Yet, few issues make difficulties the use of both methods. In recent 
times, the character-based DNA Barcodingtechnique, characterizes 
species through a unique combination of diagnostic characters[33]. 
He concluded that both COI and 16S rDNA genes well suited as 
character-based barcode markers for the neogastropod discrimination 
throughout the genus and species taxa. However, an evolutionary 
framework for the 700 species in the genus is not yet available, and 
the relationship of Conus to the other predatory snails belonging 
to the superfamily Conoidea is poorly understood. Employing 
molecular sequence data sets are suggested for delimiting species of 
this group, particularly in cases where morphological differences are 
obscure[34]. Partial sequences of mitochondrial CO栺, 16S rRNA, 
12S rRNA, nuclear ITS2, and Calmodulin genes are appropriately 
studied to understand the diversity of Gastropods at various levels 
such as population, varieties and species. Till recently the efforts on 
molecular taxonomy of the group was focused more on the higher 
taxonomic categories above species.
  Conus species were studied rather more for their pharmacological 
potential than phylogenetic understanding. The understanding of 
genetic variation as indicative of the origins of feeding divergences, 
that in turn is associated with the class of conopeptides in the venom, 
with the use of DNA sequence data from mitochondrial and nuclear 
loci provided a phylogenetic perspective for screening species for 
venom conopeptides[35]. Distinctive clustering of the species with 
similar diets was observed while mapping the known diets to the 
phylogeny of the 72 species of the genus based on mitochondrial 
16S rRNA and nuclear calmodulin gene sequences.An attempt to 
date the evolution of this different feeding modes and speciation 
of a few species was also made. The phylogenies of Conus species 
have been incompletely resolved as the employed ‘standard genes’ 
are less reliable for resolving relationships among recently diverged 
species[36]. They employed ITS2 sequences of 26 molluscivorous 
species to elucidate their evolutionary relationships and found three 
well supported clades among them.  They suggested the inclusion 
of the region in future studies considering the better resolution 
and support observed throughout the phylogenetic tree.Duda and 
Kohn[27] were studied species-level phylogenetic hypotheses based 
on nucleotide sequences of the nuclear calmodulin and mitochondrial 
16S rRNA genes of 138 Conus species. These results indicated that 
extant species from two major divergent lineages. Their geographic 
distributions suggest that one clade originated in the Indo-Pacific 
and the other in the eastern Pacific + Western Atlantic lineages of 
Conus[27].
  Duda et al[34] has provided a phylogenetic basis for evaluating 
morphological criteria and characterizing the genetic discontinuity 
to distinguish members of the Conus sponsalis species with use of 
molecular sequence data from two mitochondrial gene regions 
(16S rRNA and cytochrome oxidase subunit 栺) and one nuclear 
locus (a four-loop conotoxin gene). The genetic variation was 
hypothesized to indicate the origins of feeding divergences by using 
DNA sequence data from mitochondrial and nuclear loci 76[35]. 
The generated species-level genetic comparisons and known diets 
assisted the surveyed species phylogenic origins.The phylogeny of 
22 speciesof Conus, particularly the Conus pennaceus (C. pennaceus) 
complex, collected along the coasts of Mozambique and southern 
Angola and observed a clear genetic differentiation in both 16S 
and 12S rRNA genes between northern and southern Mozambican 
populations of the C. pennaceus species complex[37]. The study 
also pointed to a close genetic relationship between Conus lohri 
and Conus bazarutensis, as well as between Conus praelatus and C. 
pennaceus (forms of Pemba and Nacala). Phylogenetic analyses are 
essential to determine patterns of speciation and divergence. The 
monophyly of the Conoidea, characterized by a venom apparatus, 
is not questioned[38], but subdivisions within Conoidea, and 
relationships between them are controversial, mostly because the 
extensive morphological and anatomical variation encountered is 
itself not well understood. In this context, molecular perspective can 
aid in the phylogenetic classification of Conoidea.
3. Research on neurotoxic Conus peptides 
  Unquestionably, the lethality of cone snail stings motivated the 
investigation of Conus venoms. Pioneering work was done in 
Australia by Alan Kohn, who first discovered that cone snails hunted 
fish, and later the work of Robert Endean and co. documented 
pharmacological relevance of crude venoms in the 1970’s. Their 
explorations demonstrated that different cone snail venoms contain 
different biologically active components[39-41]. An early attempt to 
purify the bioactive components from cone snail venoms, carried out 
by an Australian group[42], resulted to validate a peptide composition 
by its amino acid composition; the component is known as a 毺
-conotoxin.
  Chemical synthesis began on Conus peptide, 毩-conotoxin GI, 
(from C. geographus venom) which confirmed its native amino acid 
sequence of 13-amino acids and two disulfide bonds[43]. Following 
the first venture securing milked venom’s peptide composition, a 
second attempt at finding bioactive peptides from C. geographus 
milk venom discovered the 毺-conotoxins, that were characterized 
similarly[44]. The presence of these two functional peptides in the 
venom of C. geographus also evoked how the venom of cone snail 
was effective. Containing both a potent nicotinic receptor antagonist 
(α毩-conotoxin) and sodium channel blocker (毺-conotoxin)[45], 
these molecules act synergistically to bind and inhibit different 
receptors of multiple molecular pathways responsible for the prey’s 
normal evasion behaviors. Ultimately, the work to establish the 
activity of different toxins on different receptors expressed the 
need for categorizing the paralytic peptides on the basis of their 
pharmacological targets.
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4. Conus-rich source of pharmacologically active 
peptides
  Although cone snail venoms have been intensively investigated 
over the final few decades, know that little information on whole 
conopeptide and protein content in venom ducts, particularly at 
the transcriptomic level[46]. Conus represents a large number of 
venomous marine snails containing valuable neuro-active peptides 
for developing pharmaceutical therapeutics and phyla-selective 
pesticides. Conotoxins are small peptides (usually 10–35 amino 
acids) that exhibit an extraordinary variability and selectivity over 
the range of pharmacological targets. Mass spectrometry techniques 
have revealed that the species of cone snail produces from 200 to 
1 100++ distincttoxins[46-50]. In addition to the pharmacological 
families of Conus peptides, there are structured classesthat can 
be definedby characteristic patterns of arrangement of either 
theCys residues, or the post-translationally modifiedamino acid, 
毭-carboxyglutamate[48,51]. The conopeptide mass range has 
classified according to their cysteine number; each conopeptideclass/
cysteine framework,considered masses were limitedto the mass 
range were reported in Table 1. Recently a number of cases have 
shown that the traditional identification method based on the shell 
color patterns was inadequate in distinguishing between species 
clearly identified at the genetic level[34]. These observations indicate 
that the number of conopeptides per species might exceed 1 000 and 
suggest that conopeptide diversity may be greater than expected[47]. 
These diverse mixtures of potential pharmacological agents make 
them hot targets for biomedical applications. A great number of 
research studies and large amount of data on conopeptides made 
way topool the database, ConoServer (http://www.conoserver.org), 
to help catalog the growing literature on conopeptide sequences 
and three-dimensional structures[7]. This database has now grown 
substantially and provides a valuable resource for analyzing the 
sequence and structural features of conopeptides. 
  Conus venom peptides arise from genes that are translated as pre-
pro-peptide precursors. The pharmacological active peptide is 
generated by post-translational modification of enzymatic cleavage 
at the end of the pre-pro-region. Mature conopeptides are extremely 
variable in their primary sequences, yet interestingly, the signal 
sequences of the precursor peptides are highly conserved within the 
super families[52,53]. This factor can be used to aid the identification 
of new peptides to substantiating super families.
  Regarding the primary (amino acid) sequence, conopeptides 
are associated namely as the disulfide-rich (generally termed 
conotoxins) and the non-disulfide rich peptides[50,54], although by 
convention, the conopeptides have been categorized according to 
three dimensional structure motifs (superfamily) and the selectivity 
of their pharmacological targets (family)[55]. Three large super 
families of conotoxins are well characterized: the O-superfamily 
including 氊 -, δ-, 毷 -, and 毺-conotoxins[56], the A-superfamily, of 
which the α-conotoxins belong[57], and the M-superfamily, containing 
the 毺-conotoxins[58]. Eight different T-superfamily conotoxins 
identified from five Conus species; they are among the smallest of 
the disulfide rich conotoxins[59]. The venom of cone snails has been 
the subject of intense studies because it contains small neuroactive 
peptides of therapeutic value. Yet, a little known about their larger 
protein counterparts and their role in prey envenomation. Moller 
et al[60] were analyzed the proteolytic enzymes in the injected 
venom of Conus purpurascens (C. purpurascens) and Conus ermineus 
(piscivorous), and the dissected venom of C. purpurascens, Conus 
marmoreus (C. marmoreus) (molluscivorous) and Conus virgo (C. 
virgo) (vermivorous). However, the electrophoresis patterns and sizes 
of the proteases varied considerably among these 4 species. The 
distribution of varied dramatically between the injected and dissected 
venom of C. purpurascens. Consequently, different conoproteases play 
major roles in venom processing and prey envenomation[60].
5. Structural and functional aspects of conotoxin
5.1. Conotoxins
  Conotoxins are obtained from the venom ducts of predatory 
snails of the genus Conus represent a unique arsenal of neuro-
pharmacologically active peptides that have been used as research 
tools to target voltage-gated and ligand gated ion channels and 
Table 1
Superfamilies of neurotoxic conotoxins.
Superfamily Class of cysteine arrangement Pharmacological family
Designation Pattern Designation Action
A 栺 CC-C-C α Competitive antagonist of ACh receptor
桇 CC-C-C-C-C α A Competitive antagonist of ACh receptor
桇 CC-C-C-C-C 毷 A Inhibits K
+ channels (VSPC)
M 栿 CC-C-C-CC 毺 Blocks Na
+ channels (VSSC) at site 栺
栿 CC-C-C-CC ψ Noncompetitive antagonist of ACh receptor
O 桍 C-C-CC-C-C 氊 Blocks Ca
2+ channels (VSCC)
桏 C-C-CC-C-C 氊 Blocks Ca
2+ channels (VSCC)
桏 C-C-CC-C-C 毷 Inhibits K
+ channel
桍 C-C-CC-C-C δ Delays inactivation of VSSC by binding to site 桍
桍 C-C-CC-C-C 毺 Blocks VSCC; does not compete with TTX and STX
P 桖 -C-C-C-C-C-C- Unknown
S 桒 C-C-C-C-C-C-C-C-C-C σ 5-HT3 receptor
T 桋 -CC-CC- Unknown
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receptors[61-64]. Figure 1 shows the basic scheme workflow for the 
isolation of conopeptide and screening of bioactive compounds from 
Conus sp. The toxicity of the venom is considerably more potent due 
to additive or synergistic effects of several toxins acting at different 
sites rather than from the considerable toxicity of each of the 
peptides individually[65]. 
  The major paralytic peptides of fish hunting cone venoms were 
the first to be identified[51]. In C. geographus venom, three of 
the pharmacological classes were primarily discovered. These 
conotoxins were of the α-class that target acetylcholine receptors[66], 
then 毺-class that target skeletal muscle Na
+ channels[44] and the 氊
–class that target presynaptic neuronal Ca2+ channels[51].
  α毩-Conotoxins: Alpha Conotoxins are the first toxins isolated from 
Conus venom and were designated after the 毩-toxins from snake 
venom because they inhibit the same receptor category, the muscle-
type nicotinic receptor[67,68]. Three alpha-conotoxins, G栺 G栺
A, and G栻 (from C. geographus) and M栺[from Conus magus (C. 
magus)] are homologous peptides of target selectivity possessing 13 
and 15 amino acids respectively. Each contains two disulfide bridges 
in the 3:5 loop configurations and contains a highly basic region in 
the sequence. These alpha conotoxins cause postsynaptic inhibition 
at the neuromuscular junction; the paralytic symptoms eventually 
develop into respiratory failure[69].
  氊 – Conotoxins: Omega conotoxins are peptides, composed of 24-
30 amino acids and three disulfide bonds[70]. The most characterized 
omega conotoxins are G桍A from C. geographus and omega 
conotoxins M桏A, M桏C and M桏D from C. magus venom. They 
are also known as ‘shaker peptides’ since they induce persistent 
tremors in mice intracerebrally. Conotoxins G桍A, G桍B and G桍C 
inhibit at the neuromuscular junction of skeletal muscle by blocking 
Ca2+ channels without interfering directly with the ion channels in 
the mechanism of intracellular action potentials. However, different 
effects are observed upon the three types of Ca2+ channels (L, N 
and P) during the application of G桍A. The peptide will block L 
and N types of neurons, but in muscle, only the N type is affected, 
while M桏A, specifically targets N-type Ca
2+ channels (Cav2.2) 
with little affinity to other Ca2+ channel sub types[51,71]. Also known 
as Ziconotide, M桏A has successfully completed phase 栿 clinical 
trials for two therapeutic applications of alleviating pain relatedto 
malignant disease and for non-malignant neuropathic pain; it is an 
alternative when widely used opioids become ineffective[72].
  毺-Conotoxins: 毺-Conotoxins G栿A, G栿B and G栿C are 
hydroxyproline-rich basic peptides having 22 amino acids. These 
peptides contain three hydroxyprolines and six cysteines. The 
presence of several basic Lys and Arg residues confers a high 
positive charge of +6 on G栿A and +7 on G栿B and G栿C[73,74]. 
The 毺-conotoxins act upon sodium channels in muscle, and 
limitedly in neurons. There, they bind to a site designated at the 
mouth of the Na+ channel and hinder the influx of sodium ions into 
the cell. Notably, 毺-conopeptides from species in the Conus clades 
were previously shown to target neuronal Na channel subtypes[75]. 
Recent comparative operational studiesof the structure-activity link 
of M-4毺-conotoxin G栿A[76] and M-5毺-conotoxin K栿A[77] have 
led to the identification of specific residues involved in high affinity 
interactions with Nav1.4. Recently, three new 毺-conotoxins, Bu栿A, 
Bu栿B, Bu栿C, encoded by the fish hunting species C. bullatus[78]. 
Bu栿A, Bu栿B and Bu栿C are strikingly divergent in their amino 
acid composition compared to previous m-conotoxins known to 
target the voltage gated Na channel skeletal muscle subtype Nav1.4. 
The activities of the three C. bullatus peptides were assessed on 
Nav1.4 expressed in Xenopus oocytes[78] and compared to the 
activities of a representative set of 毺-conotoxins, P栿A, G栿A, and 
K栿A[77].
δ  毮-Conotoxins: 毮–Conotoxins are one of the most intriguing 
families of conotoxins. These peptides target Na+ channels and do 
not compete with the well-known agents of competitive displacement 
such as tetrodotoxin and the 毺-conotoxins[79]. Structurally, they 
stand alone with an internalized core of disulfides that restricts 
Figure 1. Basic scheme showing the workflow for the Isolation of peptide and screening of bioactive compounds from Conus sp.
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the hydrophobic amino acids from the interior and out into the 
surrounding solvent. The hydrophobic exterior of the  毮-conotoxins 
may permit them to dissolve in the lipid membrane to interfere with 
Na+ channels through lateral binding within the lipid membrane. δ毮
-conotoxins are suspected to be essential for the rapid immobilization 
of quickly moving prey[80,81]. Barbier et al[82] reported that 毮 -E桍
A, of Conus ermineus venom, selectively acts on neuronal voltage-
dependent Na+ channels, implicating it in the excitotoxic shock and 
tetanic paralysis produced in fish. In terms of prey immobilization 
the piscivore Conus purpurascens (C. purpurascens) has shown that δ毮
-conotoxins P桍A and the 毷-conotoxin P桏A work together in rapid 
prey paralysis by inhibiting multiple targets during envenomation.
  毷-Conotoxins: 毷-P桏A was the first Conus peptide identified 
to target K+ channels. P桏A, a 27-amino acid peptide from C. 
purpurascens venom inhibits the Shaker K+ channel and has been 
chemically synthesized in the biologically active native form[83,84]; 
the disulfide connectivity of the peptide has been determined. 
Generallyclosing down of this 毷 -conotoxin is similar to that of 
the Conus Ca2+ blocking 毷 –conotoxins, nevertheless vary from the 
known K+ channel-blocking toxins from sea anemones, scorpions 
and snakes[85].
5.2. Conantokins
  The conantokins are conopeptides that target the principal 
excitatory receptors in the vertebrate central nervous system, 
the glutamate receptors[86]. The conantokins selectively inhibit a 
subtype of glutamate receptor, the N-methyl-daspartate (NMDA) 
receptors, which are ligand-gated Ca2+ channels involved in seizures 
in intractable epilepsy[87]. The conantokins have no disulfide bonds, 
but derive their crucial structural stability from post-translationally 
modified glutamic residues existing as 毭-carboxy glutamate (Gla). 
It remains unclear whether the functional role of 毭- carboxy 
glutamatic acid in other vitamin K-dependent protein is as a calcium-
binding amino acid[88].  To address this potential role for 毭-carboxy 
glutamatic acid[51,89,90] studied the role for 毭-carboxy glutamatic 
acid and discovered 毭-carboxy glutamatic acid were found higher 
amount in crude conotoxins of marine snail Conus. Conantokin G 
is a 17-residue conotoxin from the venom of C. geographus, a fish-
hunting cone snail whose venom has been known to cause human 
fatalities. Conantokin G contains five 毭 -carboxyglutamic acid 
residues; Gla 3 and Gla 4 are critical to the neurotoxin function[91].
5.3. Contulakins, contryphans and other conotoxins
  A few conopeptides are being developed as pro-drugs for 
treatment of neurological conditions. These include contulakin-G 
a glycosylated 15 amino acid conopeptide from the venom of C. 
geographus, which is being developed for acute management of 
post-operative pain[92]. The contryphans from Conus ventricosus (C. 
ventricosus) and Conus regius are the smallest bioactive conopeptides 
containing eight or nine amino acids and just one disulfide bond; 
they are distinguishable by their numerous post-translational 
modifications[93]. Although the disease target for the contryphans is 
not yet known, the peptides have been shown to elicit body tremor 
and mucous secretion when injected into fish, implying they may 
have biological activity related to endocrine or neuronal function[65]. 
The 氀-conotoxin T栺A acts as a non-competitive inhibitor of α
毩-1 adrenergic receptors[94] and the 氈-conopeptides (Mr. IA/B) 
from Conus marmoreal, that act as non-competitive inhibitors of the 
neuronal noradrenaline transporter are being developed for treatment 
of neuropathic pain[94].
  Contryphan-Vn is the first Conus peptide described from a 
vermivorous species and the first purified from the venom of the 
single Mediteranean Conus species[95]. The intramuscular injection 
of Contryphan –Vn in freshwater fishes (Poecelia pinnata) caused 
the secretion of mucous substances, a reaction was already observed 
in fish with other contryphan[96]. Massilia et al[97] were reported the 
use of dorsal unpaired median neuron cells from cockroach nerve 
cord to demonstrate that contryphan-Vn from C. ventricosus blocks 
the Ca2+-dependent K+ current. These authors also demonstrated 
the effect of the peptide on the global outward K+ current in the rat 
fetal chromaffin cells. A novel conotoxin, called Vn2, was recently 
identified in C. ventricosus, the primary structure wasdetermined[98], 
revealing a cysteine framework common to I1, I3, M, O1 and O3 
gene superfamilies. Conotoxin Vn2 displays quite a high degree 
of sequence similarity with some conotoxins targeting calcium 
channels, in particular Pn桍B from C. pennaceus[99] and an O1 
superfamily 氊-conotoxin. GST-conotoxin has been purified 
and their neurotoxic activities were assayed on the larvae of the 
moth Galleria mellonella. Results obtained indicate that indeed 
conotoxin Vn2 has strong insecticidal properties at a dose of 100 
pmol/g of body weight; it can be used for environmental friendly 
crop protection applications[100]. It is noted from this review study 
O-superfamily conotoxins are not well represented from vermivorus 
species[101]. The elucidated cDNAs of these newly found vermivorus 
toxins would facilitate a better understanding of basic research and 
drug discovery and potential pharmacological applications.
6. Recent developments
  Marine cone snails have developed sophisticated chemical 
strategies to capture prey and defend against predators. Recently, a 
毭-conotoxin-like peptide, de7a, was purified from a vermivorous 
cone snail Conus delessertii[102]. The components of the venoms 
of Conus cancellatus, a vermivorus cone collected in the western 
Gulf of Mexico, from which 6- and 4-Cys-containing peptideshave 
beenidentified[103] and similar an O-conotoxin [104] andtwo 
framework-X桇-conotoxins was purified from Conus austini[105]. 
The intracerebral injection of the peptide as 7a (500 pmol/mouse) in 
mice didn’t cause any behavioral distress compared to control mice.
The 23-amino acid peptide, called as 25a, is characterized by 
the sequence pattern CX1 CX2 CX8 CX1 CCX5, which is, for 
conotoxins, a new arrangement of six cysteines (framework XXV) 
that form three disulfide bridges. Ye et al[106] reported the isolation 
and characterization of two novel conotoxins from the venom 
of Conus imperialis. These two toxins contain a novel cysteine 
PalanisamySatheesh Kumar et al./Asian Pacific Journal of Tropical Medicine (2015)337-351 343
framework, C-C-CCC-C, which has not been found in other 
conotoxins described to date. He named as XX栿 and designates the 
two toxins im23a and im23b; cDNAs of these toxins exhibits a novel 
signal peptide sequence, which defines a new K-superfamily. The 
biological effect of conopeptide im23a and im23b and recombinant 
im23a were tested on 2-week-old (P14) Kunming male mice. 
Intracranial injection of im23a or im23b into mice induced excitatory 
symptoms; Though, the biological target of this conopepide has 
yet to be named. Various conotoxin diversifications revealed by 
a venomic study of Conus flavidus[107], has been identified 69 
nonredundant cDNA sequences and 31 conotoxin components with 
confident MSspectra. A new Q-superfamily was also identified. 
A novel peptide, RsXX桇A, was isolated from the venom duct of 
Conus regularis, a worm-hunting species collected in the Sea of 
Cortez, México[108]. This conotoxin contains 40 amino acids and 
exhibits a novel arrangement of eight cysteine residues (C-C-C-
C-CC-CC), two loops of the novel peptide are highly identical to 
the amino acid sequence of 氊-M桏A. The toxin shows an anti-
nociceptive effect in a formalin chronic pain test. However, the low 
attraction for CaV2.2 indicates that the main target of peptide could 
be different from that of 氊-M桏A[108].
  The majority of Conus venom peptides is encoded by a great 
number of gene families, and targeted selectively tobind 
voltage-gated ion channels (Na+, K+ and Ca2+ channels) and to 
membranereceptors (nAChR, 5-HT3R, NMDAR). Liu et al[109] were 
constructed cDNA libraries derived from the venom ducts C. virgo, 
C. eburneus, Conus imperialis and C. marmoreus of the South China 
Sea, to identify novel conotoxin genes and analyze the diversity 
and evolution of typical conotoxin superfamily genes from different 
Conus species. Bingham et al[110] was investigated molecular mass 
analysis of the milked venom (MV) of C. geographus, and reported 
the first insight into the composition of its deadly cocktail. This study 
identified the presence of additional highly abundant peptides that 
illustrate unknown or unassigned compounds (40%) of the observed 
MV m/z, This indicate that all the same within this well-studied C. 
geographus comprises numerous uncharacterized venom peptides, 
specifically those observed with a m/z <, similar observations are 
seen in MV from C. purpurascens[111]. Neves et al[112] identify 
disulfide-rich conotoxins in Conus crotchii using MALDI-TOF and 
mass-matching. All the conopeptides was discovered belongs to the 
A-, O1-, O2-, O3-, T- and D-superfamilies, which can block Ca2+ 
channels, inhibit K+ channels and act on nicotinic acetylcholine 
receptors (nAChRs).
7. Research on Indian cone snails 
7.1. Geographic distribution of  cone snails
  The taxonomy and distribution of Conidae in India were studied[15] 
and the diversity of cone snails in Indian Coastal waters is fairly 
well documented[1]. The principal important Conus species found 
in Indian coast are present in Figure 2. Several investigations on 
the taxonomy and distribution of Family; Conidae from the Indian 
waters carried out during 1835-2009 have recorded 81 species[115]. 
Within them Conus milneedwardsi is enlisted in the schedule 栺 of 
the Indian wildlife (Protection) act. The Conus species possess more 
or less potent venom, which is used primarily in the capture of prey. 
In Indian waters, there is only little information on the structure 
and function of the venom apparatus of cones[116,117]. Currently 
ongoing is a comparative study of the Indian species’ radula 
morphology (based on their feeding habits) and diversity of species 
composition[118]. Figure 3 provides a summary of species richness 
in different regions in Indian coast. A total of 84 species of the genus 
Conus was recorded along the Indian coast. The highest number of 
Conus species is found in Tamil Nadu coast, Gulf of Mannar (52 
species), followed by northern region (22) species, southern (6) and 
(5) species from the Palk Bay regions, with inventory numbers such 
as from Andaman and Nicobar Islands 53 species, Mumbai coast 
16 species, 14 species from Gujarat coast, 4 species from Kerala 
coast, 8 species from Andhra coast, Odisha coast 7 species,  Goa 
and Lakshadweep Islands 6 species, Puducherry coast 5 species, 
and 3 species were reported from Karnataka and West Bengal 
coast respectively (numbers represent the exact number of species 
mentioned in each citation). Geographically Conus acutangulus, and 
Conus amadis was the most widespread species, present at almost 
all stations followed by Conus arenatus, Conus ineditus, Conus 
malacanus, Conusterebra, Conustessulatus. 
  Kulkarni et al[119] were reported four fossil Conus species (Conus 
marginatus, Conus ineditus and Conus litteratus, Conus odengensis) 
from the Miocene sediments of Kachchh, Gujarat, India. 
Satheeshkumar and Khan[120] reported C. virgo and Conus bayani 
for the first time out of Pondicherry, located in the southeast coast 
of India. Recently Dalia susan et al[121] were first reported of two 
cone snails, Conus cataus and Conus ebraeus in seagrass ecosystem, 
Minicoy Island, Lakshadweep. A recently, Franklin et al[122] reported 
three Conus species’ first time in the Andaman Islands from this 
Conus coffeae was reported first time in India. The highest species 
distribution and diversity of cone snails wasobserved in the Gulf of 
Mannar (Tamil Nadu) reflects the physical conditions, microhabitats 
and other all-important resources such as food and shelter that favor 
the occurrence of the maximum number of Conus species[115]. Fifty 
two species were reported at depths <50 m in the Gulf of  Mannar 
region. In other coral reefs stations such as Andaman and Nicobar 
Island, Lakshadweep Islands, Netrani regions were reported species 
very poor with only 3-16 species respectively. Where the biogenic 
complexity of coral reefs is lacking15, few Conus species co–occur, 
for example the limestone platform at Okha, the mixed and rocky 
shores near Mumbai, and the shallow subtidal sand habitats in the 
Northern region of Tamil Nadu coast. Thus, this discrepancy appears 
to be a result of very limited knowledge of the natural history of 
Conus in India, (except  Gulf of Mannar regions) and fewer sampling 
efforts, rather than a decrease in Conus diversity and low number 
of species attributable to the limited heterogeneity of the Indian 
coasts. During 1978, Khon reported seven species as unverified 
records since no other records or any specimen deposited in the 
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museum, hence consider them all unverified. Our inventory of  84 
described species of Indian Conus is certainly incomplete in this 
perspective, with an estimated that approximately 20 species remain 
to be discovered and described. Applying molecular approaches may 
further assist in locating cryptic speciation of a single species. Acute 
toxicity of the venom of Conus zeylanicus was studied to evaluate its 
risk and toxic factors in view of human safety[123]. The lethal toxicity 
of crude venom (LD50 60 mg/kg) in mice causes increased heart rate 
and strong muscular hind limb paralysis, skeletal muscle paralysis, 
dyspnea, loss of spontaneous activity followed by respiratory failure.
Conus amadi                  C. figulinu                     C. betulinus               C. coronatus
C. marmoru              C. geographus                C. textile                   C. mustelinus
C. lividis                      C. lithographus               C. sponsalis                    C. terebr
C. tessulatus            C. zeylonicus                     C. augur                    C. aranosus
 
Figure 2. Important Conus sp. present in Indian coast.
 
Figure 3. Cone snails distribution in Indian coast.
Station 1, Dwarka; Station 2, Kachch; Station 3, Veraval; Station 4, Kodinar; 
Station 5, Okha; Station 6, Kollam; Station 7, Malabar; Station 8, Mumbai; 
Station 9, Calicut; Station 10, Mandapam; Station 11, Pamban; Station 12, 
Vedalai; Station 13,  Keelakarai; Station 14, Goa; Station 15, Tuticorin; 
Station 16; Puducherry; Station  17, Cuddalore; Station 18, Chennai; Station 
19, Parangipettai; Station 20, Tranquebar; Station 21, Nagapattinam; Station 
22, Vishakhapatnam; Station 23, Kanyakumari; Station 24, Andaman and 
Nicobar Island; Station; Station 25, Netrani-Karanatka; Station 26, Gopalpur-
Orissa; Station 27, Kolkatta; Station 28, Minicoy Island-Lakshadweep.
7.2. Diversity of conopeptide in Indian cone snails
  This review focuses on some of the pharmacological important 
peptides from Indian cone snails. India has a diversity of 20%-
30% of total cone snail species distributed worldwide. A group 
of promising Indian scientists has established drug discovery 
programs from Conus peptides[55,124-127]. The summary of novel 
conotoxin isolated from Indian cone snails are given in Table 
2.Mass spectrometry offers a powerful and rapid way of probing 
the composition of peptide mixtures. A novel 13-residue peptide 
Mo1659 has been isolated from the venom of a vermivorous cone 
snail, Conus monile[124]. The sequence (FHGGSWYRFPWGY-
NH2), corresponding to a calculated average mass of 1659.8 Daltons 
were reported. It appears to be the first non-disulfide bonded 
peptide, which influences K+ currents in neurons. Mandal et al[129] 
had independently been investing the peptide components of the 
venom from C. virgo and had completed the sequence assignment 
Table 2 
Novel conotoxin isolated from Indian cone snails.
Species Name of peptide Sequence Target Reference
C. amadis Am2766 CKQAGESCDIFSQNC- Na+ channel [126]
CVGTCAFICIE-NH2
C. monile Mo1659 FHGGSWYRFPWGY-NH2 K
+ channel [127]
C. loroisii Lo959 GCPDWDPWC- NH2 Ca
2+ channel [87]
C. achatinus Ac 6.1 DECFSPGTFCGIKPGLCCSAWCYSFFCLTLTF Voltage gated Na+ channel [130]
Ac 6.2 DECYPPGTFCGIKPGLCCSERCFPFVCLSLEF Voltage gated Na+ channel [130]
Ac 6.3 YECYSTGTFCGVNGGLCCSNLCLFFVCLFS Voltage gated Na+ channel [130]
Ac 6.4 CKGKGASCSRTMYNCCTGSCNRGKCG [130]
Ac 6.5 ATDCIEAGNYCGPTVMKICCGFCSPFSKICMNYPQN Voltage gated Ca2+ channel [130]
C. virgo Vi1359 Z*CCITIPECCRI-NH2 Pyroglutamic acid residue [129]
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of the peptide MALDI Mass spectrometry. Distinctly different 
effects of two closely related contryphans have been demonstrated 
on voltage-activated Ca2+ channels[87]. The peptides Lo959 and 
Am975 were isolated from Conus loroisii, a vermivorous marine 
snail and Conus amadis, a molluscivore, respectively. The peptide 
sequences of Lo959 and Am975 were derived by mass spectrometric 
sequencing (MALDIMS/MS) and confirmed by chemical synthesis. 
The sequences of Lo959, GCPDWDPWC-NH2 and Am975, 
GCODWDPWC-NH2 (O: 4-trans-hydroxyproline: Hyp), vary only 
at residue 3; Pro in Lo959, Hyp in Am975, which is identical to 
contryphan-P, earlier derived from C. purpurascens, a piscivore; 
while Lo959 is a novel peptide. Mandal and Balaram[129] were 
reported mass spectrometric identification of pyroglutamic acid in 
peptides following hydrolysis. During the course of fractionating 
crude venom from C. virgo using reverse-phase high-performance 
liquid chromatography was encountered two closely related peptide 
components with a mass of 1 359 Da (Vi1359) and 1 361 Da 
(Vi1361). Gowd et al[130] were reported the sequencing of cDNA 
derived using O-superfamily specific primers yielded five complete 
conotoxin precursor sequences (Ac 6.1 to Ac 6.5)毮, 氊, and 氊-like 
conotoxins. Although he concluded a crude venom analysis should 
prove powerful in studying both inter-and-intra species variation in 
peptide libraries.Saravanan et al[131] isolated conotoxin from Conus 
figulinus, biological activity studies were performed with the purified 
toxin containing proteolytic peptides, which inhibit the trypsin and 
chymotrypsin enzymes. The genus Conus presents vast opportunities 
for research in the fields of biochemistry, natural products, evolution, 
and clinical medicine. However, there are many fields related to 
Conus venom peptides are least known, and in others the available 
data should be updated and retooled. Many most conscious species 
are yet to discover in Indian coast, contributing to our accumulating 
knowledge of this unique group.
8. Therapeutic application of Conus conopeptides 
  Research into the pharmacological properties of marine natural 
products has led to the discovery of many potentially active agents 
considered worthy of clinical application[132], and a variety of 
biologically active constituents have been isolated from various 
species of Conus[133-136]. The extraordinary pharmacological 
selectivity of conopeptides has caused a dedication in characterizing 
them and diversifying their applications. The summary of the 
therapeutic applications of conopeptides was described in Table 3. 
  The 氊-conotoxins are heavily used in Neuro- and pharmacological 
research to study the function of Ca2+ channel subtypes. Due to 
their specific binding properties, conopeptides proved useful tools 
to acquire structural information about their corresponding targets. 
Interestingly, recent data obtained by solid-state NMR suggest 
the binding of peptide toxins to their target induce conformational 
changes of both binding components[137]. These results can infer 
that some conformational dynamics take place during drug–target 
interactions. Since voltage-gated and ligand-gated ion channels are 
involved in a variety of different physiological functions, certain 
conopeptides function as leads for new drugs. Currently, several 
conopeptides are currently undergoing clinical trials. However, the 
application of peptides as drugs is constrained so the actual peptide 
may be modified or redesigned to mimic its original function; 
the new chemical structure is designed to have improvements 
in molecular stability, biological activity, cell permeability, 
administration, etc. Nevertheless, these peptides competently serve in 
the development of drug candidates from existing natural compounds 
and further our confidence and reliance upon using natural templates 
for structural design.
  The first conopeptide used as a drug for the treatment of intractable 
pain is 氊-conotoxin M桏A (Ziconitide, Prialt®) from C. magus[138-
140] and is currently completing a repeat of Stage栿clinical trials for 
the treatment of cancer pain[139]. Ziconotide has also been tested 
for neuro-protection as its efficacy has been tested against ischemic 
stroke and in coronary bypass surgery[142]. However, these human 
neuro-protection trials have been disappointing and abandoned[142]. 
Recently, other conopeptides with analgesic activity have been 
identified in the venom of the fish-eating snail, Conus catus[70], 
the molluscivorous C. marmoreus[143], and Conus victoriae[144]. It 
Table 3 
Therapeutic applications of conopeptides.
Conopeptide Sequence Target Clinical application Reference
α毩-Vc1.1 (ACV1) GCCSDPRCNYDHPEIC* nAChR (毩α9α毩α10) Pain Phase I [141, 176]
氈-MrIA(Xen2174) NGVCCGYKLCHOC Norepinephrine transporter Pain Phase I [177]
Contulakin-G (CGX-
1160)
ZSEEGGSNATKKPYIL Neurotensin receptor Pain Phase I [59]
GE毭毭LQ毭NQ毭LIR毭KSN* NMDA receptor (NR2B) Epilepsy Phase I [92, 178, 179]
Conantokin-G
(CGX-1007)
CKSKGAKCSKLMYDCCSGSCSGTVGRC* Ca2+ channel (CaV2.2) Pain Phase I [70, 143]
Conantokin-G
(CGX-1007)
GE毭毭LQ毭NQ毭LIR毭KSN* NMDA receptor (NR2B) Pain/ Neuroprotection Preclinical [92, 180)]
毷-PVIIA (CGX-1051) CRIONQKCFQHLDDCCSRKCNRFNKCV K
+ channel(KV1) Myocardial infarction Preclinical [146]
毺-conotoxins Various Na
+ channels Pain Preclinical [145, 181]
氊-MVIIA
(Ziconotide,Prialt®)
CKGKGAKCSRLMYDCCTGSCRSGKC* Ca2+ channel (CaV2.2) Pain FDA
approved
[71,182]
Z, pyroglutamate; O, 4-trans-hydroxyproline; 毭, 毭-carboxyglutamate; T, O-glycosylated threonine; *, C-terminal amidation; nAChR, nicotinic acetylcholine 
receptor;  NMDAR, N-methyl-D-aspartate receptor. A derivative of 氈-MrIA, rather than the native peptide, advanced to human clinical trials.
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preliminarily appears that Conus has included an analgesic among 
its lethal components of the venom to pacify its victim as part of the 
immobilization strategy. The finding that these marine invertebrate 
neurotoxins and analgesic peptides from Conus are effective in 
humans has opened a treasure chest of potential drugs from the sea 
for commercial development as clinical pharmaceuticals.
  Besides their use as pain killers, conopeptides are useful for other 
clinical indications. It has been demonstrated that 毷-conotoxin P
桏A reduces the size of the myocardial infarct in an ischemia/
reperfusion model in rabbits, rats, and dogs in vivo[145,146]. 
Additionally, other conopeptides are also being evaluated for other 
neurological symptoms[147-149]. Venom studies in C. bullatus 
have already yielded results of exceptional pharmacological 
interest. The best characterized C. bullatus venom component, the 
alpha conotoxin Bu栺A is a small peptide antagonist of nicotinic 
receptors that has become the standard pharmacological tool 
for differentiating nicotinic receptor subunits, b2 and b4. These 
receptors are of considerable interest in Parkinson’s disease[150]. The 
recent identification of alpha-5 and alpha-6 subunits contributing 
to the nAChRs expressed on striatal dopaminergic terminals opens 
up the possibility of developing selective nAChR ligands active on 
dopaminergic systems and associated diseases, such as Parkinson’s 
disease[152,153]. 
  Both conantokins and conotoxins have potential applications 
in Alzheimer’s disease. With regards to the conantokins, it has 
been proposed that over excitation mediated by specific NMDA 
receptors might contribute to localized brain damage in Alzheimer’s 
disease. Revised conantokins are valuable for identifying the 
NMDA receptors involved and may have potential as protective 
agents[153,154]. This increase a possibleness that the 500-700 species 
of cone snails may supply a maximum of 100 000 compounds of 
potential biomedical attention, possibly more when all the species 
of family Conidea are considered[151]. A Further comparison with 
proteomic and genomic data will lead to a better understanding of 
conopeptides diversity and the underlying mechanisms involved in 
conopeptide evolution.
9. Conclusion
  Marine pharmacology research on Conus conotoxin during 1982-
2013 was truly global in nature involving investigators from many 
countries lead to discover novel therapeutic peptides. The data 
presented here undoubtedly indicate the great value of marine 
natural products as well as marine-derived analogs of novel peptide 
that make them important candidates for further pharmaceutical 
studies for therapeutic applications of various diseases. The 
vast array of combinatorial libraries of conopeptides remains 
pharmacologically uncharacterized, the enormous opportunity 
remains discovered potential therapeutics from amongst the highly 
diverse venoms. Based on the present study, 84 species of Conus are 
now recognized as occurring in Indian waters, from the intertidal 
zone to 200 m depths. The examinations of cone snail’s venom 
components from discovery into novel drug development are scarce 
in India. Continued preclinical and clinical research with Conus 
peptide demonstrating a broad spectrum of pharmacological activity 
will probably result in novel therapeutic agents for thetreatment of 
multiple disease categories. In general, studies on Indian Conus are 
necessary and should be done in terms of monographic works, and 
scientists there should be encouraged to study other aspects of this 
animal. In conclusion, we remain convinced that the Indian EEZ 
still contains valuable “cone snails” waiting to bemined by inquiring 
medicinal chemists as well as drug discovery.
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